In terms of anti-inflammatory effects, it suppresses the production of pro-inflammatory cytokines—including TNF-α, IL-1β, and IL-6—which are crucial contributors to the chronic inflammatory milieu in IPF (Conte et al., 2014; Jin et al., 2019). The gene discussed is IL1B; the disease is idiopathic pulmonary fibrosis.